Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.

EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) todayMaximize Your Portfolio with Data Driven ...

EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...

Low-cost passive index investing (in the S&P 500 or Nasdaq 100) has been key to impressive results in recent years. However, with much of the outsized gains coming from just a handful of names (at the ...

Explore Cathie Wood's latest investment insights on the convergence of artificial intelligence in shaping the future, as ...

With the respite in U.S. tariffs on key countries, investors could turn their attention to earnings. But Alphabet earnings ...

ARK Invest's 13F portfolio value increased by ~10% to ~$12B this quarter. Check out the top holdings and new stakes of the ...

Feb. 4, 2025, Cathie Wood-led Ark Invest dumped $7.4 million worth of Palantir stock even as the shares rose 24% over ...

Cathie Wood says most profound application of AI is in healthcare. She particularly expects Recursion Pharma and Illumina to ...

Ark Invest CEO and CIO Cathie Wood joins 'Squawk Box' to discuss her big ideas of 2025, investing in AI technology, impact of ...